Tong Lu Selected Research

Ureteral Obstruction

1/2022

Antibody-drug conjugates targeting CD248+ myofibroblasts effectively alleviate renal fibrosis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tong Lu Research Topics

Disease

49	Neoplasms (Cancer) 01/2024 - 01/2012
18	Adenocarcinoma of Lung 12/2023 - 01/2018
7	Insulin Resistance 12/2018 - 07/2003
6	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2015
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2018
6	Obesity 06/2023 - 07/2003
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 12/2020
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023 - 12/2019
5	Type 2 Diabetes Mellitus (MODY) 06/2023 - 01/2004
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2020
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2022 - 12/2019
5	Carcinogenesis 04/2021 - 01/2018
4	Inflammation (Inflammations) 05/2024 - 01/2021
4	Lung Neoplasms (Lung Cancer) 11/2023 - 09/2012
4	Breast Neoplasms (Breast Cancer) 11/2022 - 04/2016
4	Diabetes Mellitus 07/2012 - 12/2008
3	Pain (Aches) 02/2024 - 08/2023
3	Body Weight (Weight, Body) 02/2024 - 10/2017
3	Bites and Stings (Sting) 01/2024 - 01/2021
3	Nausea 01/2024 - 01/2021
3	Residual Neoplasm 12/2023 - 12/2021
3	Nasal Polyps (Nasal Polyp) 11/2023 - 01/2020
3	Rhinosinusitis 11/2023 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2022
3	Esophageal Squamous Cell Carcinoma 09/2022 - 06/2021
3	Fibrosis (Cirrhosis) 01/2022 - 02/2006
2	Kidney Neoplasms (Kidney Cancer) 02/2024 - 01/2024
2	Postoperative Pain 01/2024 - 08/2023
2	Vomiting 01/2024 - 01/2021
2	Macular Degeneration (Age-Related Maculopathy) 11/2023 - 03/2013
2	Genomic Instability 11/2023 - 01/2021
2	Cognitive Dysfunction 10/2023 - 01/2023
2	Hypertension (High Blood Pressure) 01/2022 - 10/2016
2	Gastroparesis 08/2021 - 01/2021
2	Allergic Rhinitis 01/2021 - 01/2019
2	Necrosis 10/2020 - 07/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 12/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2003
14	Biomarkers (Surrogate Marker)IBA 11/2023 - 09/2012
10	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2021
9	polatuzumab vedotinIBA 04/2024 - 01/2020
8	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 02/2024 - 09/2006
8	Messenger RNA (mRNA)IBA 11/2023 - 07/2003
7	Rituximab (Mabthera)FDA Link 04/2024 - 12/2019
7	MicroRNAs (MicroRNA)IBA 12/2023 - 06/2017
7	Circular RNAIBA 04/2021 - 01/2018
7	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 03/2004
6	EnzymesIBA 07/2023 - 05/2005
6	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2020
5	venetoclaxIBA 12/2023 - 12/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 01/2020
3	Long Noncoding RNAIBA 12/2023 - 01/2018
3	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2020
3	AntigensIBA 01/2023 - 11/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2012
3	Bendamustine Hydrochloride FDA Link 01/2023 - 12/2020
3	mRNA VaccinesIBA 09/2022 - 01/2022
3	Neoplasm Antigens (Tumor Antigens)IBA 09/2022 - 01/2022
3	LipidsIBA 01/2022 - 07/2004
3	Small Interfering RNA (siRNA)IBA 04/2021 - 01/2015
3	Insulin (Novolin)FDA Link 05/2005 - 07/2004
2	Prednisone (Sone)FDA LinkGeneric 04/2024 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 01/2020
2	Remifentanil (Ultiva)FDA Link 02/2024 - 01/2024
2	Blood Glucose (Blood Sugar)IBA 02/2024 - 10/2017
2	Peptides (Polypeptides)IBA 12/2023 - 11/2021
2	Ranibizumab (Lucentis)FDA Link 11/2023 - 03/2013
2	CytokinesIBA 07/2023 - 08/2005
2	AntibodiesIBA 06/2023 - 01/2023
2	Small Cytoplasmic RNAIBA 06/2023 - 01/2023
2	camrelizumabIBA 01/2023 - 01/2022
2	monomethyl auristatin EIBA 01/2023 - 01/2020
2	InterferonsIBA 01/2023 - 02/2006
2	Cancer VaccinesIBA 09/2022 - 01/2022
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2022
2	hinokiflavoneIBA 01/2022 - 01/2022
2	obinutuzumabIBA 12/2021 - 01/2020
2	Contrast MediaIBA 08/2021 - 11/2019
2	HhAntag691IBA 01/2021 - 01/2020
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 07/2010
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2019
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 07/2010
2	IronIBA 10/2020 - 11/2012
2	Competitive Endogenous RNAIBA 02/2020 - 01/2019
2	PowdersIBA 11/2019 - 12/2018
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2019 - 01/2015
2	CreatinineIBA 01/2019 - 04/2017
2	Cystatin CIBA 01/2019 - 04/2017

Therapy/Procedure

16	Therapeutics 02/2024 - 01/2016
8	Immunotherapy 11/2023 - 01/2020
6	Drug Therapy (Chemotherapy) 11/2022 - 04/2016
3	Length of Stay 01/2024 - 12/2019
2	Nephrectomy 02/2024 - 01/2024
2	Analgesia 02/2024 - 01/2024
2	Cystectomy 01/2024 - 01/2012
2	Photothermal Therapy 02/2023 - 10/2020
2	Glycemic Control 01/2023 - 12/2018
2	Aftercare (After-Treatment) 12/2019 - 05/2005
2	Lasers (Laser) 11/2019 - 09/2012